Pueraria mirifica clinical study in Premenopausal women
Medicinal Plant Research Institute, Department of Medical Sciences, Ministry of Public Health, Thailand; July 2000
Clinical Study : Premenopausal Women
Product type : Pueraria mirifica Premium Grade
Function : Health Food (Food Supplement)
Test Period : 2 months
Number of Testers :
32 consumer 400 mg/day, 15 days/month
34 consumer 800 mg/day, 15 days/month
The results are summarized in following details as in below;
The placebo group contains 31 testers, had received tapioca starch filled capsule to consume 2 capsules/day for 15 days/month started from the first day of the menstruation period, for 2 consecutive months. This group showed no significance change in all record parameters.
The first tested group contains 32 testers, had received 200 mg @ 2 capsules each per day of Pueraria mirifica filled capsule in the same condition as the placebo group.
This group showed significance change with different number in all recorded parameters, including mammary pain (44%) which is related to Breast firmness and may relate also to breast enlargement, skin recovering (88%), healthier hair (75%), charisma clearance (100%), increase vaginal secretion (44%), healthier menstruation (6%), breast firmness (44%), breast enlargement (9%), and hip enlargement (9%)
The second tested group contains 34 testers, had received 200 mg @ 4 capsules – Pueraria mirifica filled capsule to consume 4 capsules/day in the same condition as the placebo group.
In conclusion, the human test as a food supplement or functional food product has shown its estrogenic effects clearly among testers, including skin reformed, hair complexity, breast firmness, and possible to induce breast enlargement.
Pueraria mirifica studies
Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study
The effect of Pueraria mirifica on cytologic and urodynamic findings in ovariectomized rats.Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women.
Challenges in the conduct of Thai herbal scientific study: efficacy and safety of phytoestrogen, pueraria mirifica (white kwao krua) phase I, in the alleviation of climacteric symptoms in perimenopausal women.